Stockreport

OverT Bio Receives $120K G-Rex® Grant to Propel Solid Tumor Cell Therapy Advancements [Yahoo! Finance]

Bio-Techne Corp  (TECH) 
Last bio-techne corp earnings: 4/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bio-techne.com
PDF The grant will aid in the optimization of cell manufacturing processes and accelerate the development of OverT Bio's products, which are based on innovative data-driven [Read more]